OXYBUTYNIN CHLORIDE
| Brand name | GELNIQUE |
|---|---|
| Active ingredient | OXYBUTYNIN CHLORIDE |
| Strength | 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | GEL |
| Route | TRANSDERMAL |
| Modality | Small molecule |
| FDA approval | January 2009 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8920392 | March 2031 | use U-1644 |
| 10449173 | November 2029 | product |
| 9259388 | November 2029 | use U-1644 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.